CASCADIAN THERAPEUTICS INC (USA)

Diferido Nasdaq  - 
- USD   -.--%
2016CASCADIAN THERAPEUTICS INC (USA) : REVERSE SPLIT: 1 para 6
FA
 ResumenNoticiasEmpresa 
Perfil de la empresa
Más información sobre la empresa
Todas las noticias sobre CASCADIAN THERAPEUTICS INC (USA)
2016CASCADIAN THERAPEUTICS INC (USA) : REVERSE SPLIT: 1 para 6
FA
Más noticias
Noticias en otros idiomas sobre CASCADIAN THERAPEUTICS INC (USA)
2018Cascadian Therapeutics Announces 2018 Outlook and Recent Progress
2018Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European M..
2017Cascadian Therapeutics Added to the Nasdaq Biotechnology Index
2017Prolonged Progression-Free Survival Reinforces Tucatinib's Potential for Patients with ..
2017Cascadian Therapeutics Reports Third Quarter 2017 Financial Results
Más noticias
Directivos y Administradores
Nancy C. Whiting President, Secretary & Director
Venkat Ramanan Vice President-Finance
Todd E. Simpson Director
Jean I. Liu Director
Sector y competencia
Var. 1EneCapi. (M$)
CASCADIAN THERAPEUTICS INC (USA)170.81%0
GILEAD SCIENCES, INC.-13.29%78 912
VERTEX PHARMACEUTICALS34.12%75 532
REGENERON PHARMACEUTICALS, INC.-0.45%67 214
WUXI APPTEC CO., LTD.-20.33%40 830
BIONTECH SE-37.80%38 968